What Legal Risks Should Companies Review in a Spac Transaction?

The SPAC transaction timeline typically spans 12 to 18 months from formation to closing. A SPAC is a blank-check corporation created to raise capital and identify an acquisition target within a defined window, usually 24 months. Once a target is identified, the SPAC board negotiates valuation, conducts legal and financial diligence, and prepares merger documentation. The SEC requires detailed disclosure of the target's financial condition, business model, risks, and pro forma projections in a registration statement on Form S-4. SPAC shareholders then vote on the proposed combination, with the merger agreement specifying consideration, representations and warranties, and conditions to closing.

One critical risk is shareholder redemption. SPAC shareholders may redeem their shares for cash if they disapprove of the proposed target, reducing capital available to the combined entity at closing. Target companies and SPAC sponsors must model redemption scenarios and ensure sufficient capitalization remains after redemptions. Legal counsel must verify that the merger agreement contains appropriate representations, indemnification provisions, and termination rights to protect both parties.

SEC compliance is central to SPAC transaction execution. The SEC has issued guidance imposing heightened disclosure standards regarding financial projections, conflicts of interest, and risk factors. Target company disclosure must be comprehensive and accurate; material misstatements or omissions can expose the SPAC, its directors, and the target company to liability under Section 11 of the Securities Act of 1933 and Section 10(b) of the Securities Exchange Act of 1934.

The merger agreement typically includes representations and warranties from the target company covering financial statements, business operations, contracts, litigation, regulatory compliance, and intellectual property. These representations establish baseline expectations and provide grounds for indemnification claims if breached. The SPAC must file a Form S-4 with the SEC, combining the registration statement for the post-merger company's securities with a proxy statement seeking shareholder approval. The SEC review process can take several weeks to several months, depending on target complexity and disclosure quality. SEC comments may require supplemental filings and delay the shareholder vote.

When a SPAC transaction involves a target company with significant New York operations or assets, counsel must consider state-level regulatory filings, licensing requirements, and industry-specific approvals. For example, targets in aerospace and defense sectors may require Department of Defense or export control review, extending the regulatory timeline. Practitioners should verify all state and federal compliance obligations early to avoid last-minute delays at closing.

Diligence is the mechanism by which the SPAC verifies the accuracy of target company representations before committing to the merger. Legal diligence typically covers contract review, litigation history, regulatory compliance, employment matters, and intellectual property ownership. Financial diligence examines revenue recognition, cost allocation, working capital trends, and customer concentration.

The target company must produce extensive documentation, including audited financial statements, tax returns, board minutes, material contracts, and regulatory filings. Delays in document production or discovery of undisclosed liabilities can jeopardize the transaction timeline or valuation. The merger agreement typically contains a material adverse change (MAC) clause, which permits the SPAC to terminate the transaction if the target experiences a material decline in business, earnings, or asset value between signing and closing. MAC clauses are narrow and fact-intensive; courts rarely find that a MAC has occurred unless the impact is severe and not foreseeable at signing.

Target company counsel must carefully negotiate the scope of representations, the survival period for indemnification claims, and caps on indemnification liability. A representation survival period of 12 to 24 months post-closing is common, meaning the combined entity can bring indemnification claims within that window if a representation was false at signing. Counsel should also address escrow arrangements, which hold back a portion of merger consideration to fund indemnification claims, and ensure that survival periods and escrow terms align with the target's risk appetite.

SPAC shareholder approval is a critical gate. The proxy statement must disclose the proposed merger terms, the target company's financial projections, conflicts of interest, and financing arrangements or sponsor commitments. The vote typically requires approval by a majority of shares present and voting. Shareholders who vote against the merger generally retain the right to redeem their shares at net asset value, typically $10 per share, before the vote.

Redemption risk is substantial. If a large percentage of SPAC shareholders redeem, the combined entity may lose significant capital, forcing the target company to reduce headcount or defer growth initiatives. The merger agreement often includes a minimum cash condition, which allows either party to terminate if cash available after redemptions falls below a specified threshold. SPAC sponsors typically commit to not redeem their shares and may agree to fund additional capital to ensure the transaction closes with adequate capitalization.

In some transactions, the SPAC arranges a private investment in public equity (PIPE) commitment from institutional investors who agree to purchase shares at the merger closing price, regardless of redemptions. A PIPE stabilizes the capital base and signals confidence to public shareholders. However, PIPE investors conduct their own diligence and may withdraw if material adverse developments emerge before closing. Counsel must ensure that PIPE commitments are sufficiently binding to provide reliable funding.

After the merger closes, the combined entity assumes public company obligations, including quarterly and annual SEC reporting, Sarbanes-Oxley compliance, audit committee oversight, and disclosure controls. The legacy target company must establish or enhance its finance, legal, and compliance infrastructure to meet these requirements. Integration planning should begin during the diligence phase to ensure a smooth transition and minimize operational disruption.

Some SPAC transactions include earnout provisions where additional merger consideration is paid if the target achieves specified financial or operational milestones within 12 to 36 months post-closing. Earnout provisions require clear documentation of performance metrics, measurement methodology, and dispute resolution process. The combined entity must also address any changes in control triggered by the merger, including contract consents, financing covenant compliance, and employee retention agreements. Key employees may have change-of-control provisions that accelerate vesting or trigger severance payments. Understanding and negotiating these obligations early prevents post-closing surprises and supports retention of critical talent.

Our firm regularly advises corporations pursuing SPAC transactions, from initial target identification through post-closing integration. We provide guidance on SPAC transaction structuring, regulatory compliance, and risk allocation in merger agreements. For target companies in specialized sectors, such as aerospace and defense, we coordinate regulatory review and manage sector-specific compliance obligations to ensure a streamlined closing process.

Corporations considering a SPAC combination should evaluate the SPAC sponsor's track record, the target's strategic fit, and the post-merger capital structure. Ensure that diligence is thorough, representations are negotiated carefully, and the merger agreement contains clear termination rights and indemnification protections. Document all material assumptions, including redemption scenarios and financing commitments, before shareholder approval. Early coordination with securities counsel, tax advisors, and industry specialists will clarify timeline expectations and identify regulatory or operational risks that could delay the transaction.